Indaptus Therapeutics GAAP EPS of -$0.46 beats by $0.45

Aug. 08, 2022 8:53 AM ETIndaptus Therapeutics, Inc. (INDP)By: Pranav Ghumatkar, SA News Editor
  • Indaptus Therapeutics press release (NASDAQ:INDP): Q2 GAAP EPS of -$0.46 beats by $0.45.
  • As of June 30, 2022, the Company had cash, cash equivalents and short-term investments of approximately $33.0 million. As of December 31, 2021, the Company had cash and cash equivalents of approximately $39.1 million.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.